ANAPTYSBIO INC (ANAB) Stock Earnings Estimates
NASDAQ:ANAB • US0327241065
53.08 USD
-1.82 (-3.32%)
At close: Feb 13, 2026
53.08 USD
0 (0%)
After Hours: 2/13/2026, 8:00:00 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.29M -83.71% | 17.157M 66.73% | 91.28M 432.03% | 214.97M 135.51% | 127.21M -40.82% | 181.96M 43.04% | 292.38M 60.68% | 326.32M 11.61% | 492.81M 51.02% | 701.54M 42.36% | 881.18M 25.61% | 1.129B 28.12% | |
| EBITDA YoY % growth | -114.47M -103.72% | -156.42M -36.65% | -114.343M 26.90% | -8.16M 92.86% | -5.355M 34.38% | 20.227M 477.72% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -115.15M -102.69% | -157.072M -36.41% | -114.949M 26.82% | 24.12M 120.98% | -89.444M -470.83% | -169.789M -89.83% | -135.404M 20.25% | -77.496M 42.77% | 95.691M 223.48% | 340.17M 255.49% | 507.24M 49.11% | 785.73M 54.90% | |
| Operating Margin | -1,119.05% | -915.50% | -125.93% | 11.22% | -70.31% | -93.31% | -46.31% | -23.75% | 19.42% | 48.49% | 57.56% | 69.60% | |
| EPS YoY % growth | -4.57 -122.93% | -6.08 -33.04% | -5.21 14.31% | -1.29 75.27% | -4.67 -262.10% | -5.50 -17.85% | -3.18 42.07% | -1.83 42.67% | 3.65 300.00% | 7.41 102.93% | 10.89 47.01% | 15.24 39.89% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.94 230.39% | -1.07 16.22% | -1.01 24.77% | -1.21 -333.44% | -0.99 -205.53% | -0.38 64.43% | -0.41 59.63% | -0.44 64.12% | -0.47 52.85% |
| Revenue Q2Q % growth | 93.892M 117.78% | 27.076M -2.50% | 29.356M 31.86% | 31.394M -58.87% | 37.788M -59.75% | 22.708M -16.13% | 22.708M -22.65% | 22.708M -27.67% | 22.708M -39.91% |
| EBITDA Q2Q % growth | -8.16M 9.97% | -12.505M 54.35% | -11.342M 56.18% | -10.067M -128.66% | 55.712M 782.75% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 43.839M 553.35% | -21.039M 23.60% | -19.995M 23.59% | -24.509M -170.62% | -30.226M -168.95% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.52 145.61% | -1.47 | 1.99 | 135.42% |
| Q2 2025 Q2Q % growth | -1.34 21.64% | -1.57 | 0.23 | 14.78% |
| Q1 2025 Q2Q % growth | -1.28 21.95% | -1.28 | 0.00 | -0.12% |
| Q4 2024 Q2Q % growth | -0.72 54.72% | -1.65 | 0.93 | 56.40% |
| Q3 2024 Q2Q % growth | -1.14 19.15% | -1.68 | 0.54 | 32.14% |
| Q2 2024 Q2Q % growth | -1.71 -14.00% | -1.01 | -0.70 | -69.51% |
| Q1 2024 Q2Q % growth | -1.64 -3.80% | -1.60 | -0.04 | -2.69% |
| Q4 2023 Q2Q % growth | -1.59 -70.97% | -1.63 | 0.04 | 2.65% |
| Q3 2023 Q2Q % growth | -1.41 -19.49% | -1.83 | 0.42 | 22.95% |
| Q2 2023 Q2Q % growth | -1.50 -30.43% | -1.73 | 0.23 | 13.36% |
| Q1 2023 Q2Q % growth | -1.58 -20.61% | -1.07 | -0.51 | -47.81% |
| Q4 2022 Q2Q % growth | -0.93 17.70% | -0.98 | 0.05 | 4.74% |
| Q3 2022 Q2Q % growth | -1.18 -391.67% | -0.74 | -0.44 | -59.94% |
| Q2 2022 Q2Q % growth | -1.15 -5,650.00% | -1.04 | -0.11 | -10.35% |
| Q1 2022 Q2Q % growth | -1.31 -98.48% | -1.01 | -0.30 | -29.08% |
| Q4 2021 Q2Q % growth | -1.13 -194.17% | 2.62 | -3.75 | -143.06% |
| Q3 2021 Q2Q % growth | -0.24 72.41% | -0.93 | 0.69 | 74.10% |
| Q2 2021 Q2Q % growth | -0.02 97.47% | -0.11 | 0.09 | 81.70% |
| Q1 2021 Q2Q % growth | -0.66 -120.00% | -0.70 | 0.04 | 5.95% |
| Q4 2020 Q2Q % growth | 1.20 | 1.42 | -0.22 | -15.48% |
| Q3 2020 Q2Q % growth | -0.87 | -0.74 | -0.13 | -18.25% |
| Q2 2020 Q2Q % growth | -0.79 | -0.76 | -0.03 | -3.29% |
| Q1 2020 Q2Q % growth | -0.30 | -0.64 | 0.34 | 53.31% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 76.32M 154.26% | 16.128M | 60.192M | 373.21% |
| Q2 2025 Q2Q % growth | 22.263M 102.93% | 11.783M | 10.48M | 88.94% |
| Q1 2025 Q2Q % growth | 27.771M 286.84% | 15.579M | 12.192M | 78.26% |
| Q4 2024 Q2Q % growth | 43.113M 378.77% | 7.923M | 35.19M | 444.15% |
| Q3 2024 Q2Q % growth | 30.017M 804.67% | 7.01M | 23.007M | 328.20% |
| Q2 2024 Q2Q % growth | 10.971M 217.08% | 24.787M | -13.816M | -55.74% |
| Q1 2024 Q2Q % growth | 7.179M 422.49% | 4.047M | 3.132M | 77.39% |
| Q4 2023 Q2Q % growth | 9.005M 32.23% | 2.273M | 6.732M | 296.17% |
| Q3 2023 Q2Q % growth | 3.318M 157.21% | 2.481M | 837K | 33.74% |
| Q2 2023 Q2Q % growth | 3.46M 183.61% | 3.388M | 72K | 2.13% |
| Q1 2023 Q2Q % growth | 1.374M 41.65% | 3.647M | -2.273M | -62.33% |
| Q4 2022 Q2Q % growth | 6.81M 574.26% | 6.967M | -157K | -2.25% |
| Q3 2022 Q2Q % growth | 1.29M -93.82% | 10.55M | -9.26M | -87.77% |
| Q2 2022 Q2Q % growth | 1.22M -95.94% | 4.808M | -3.588M | -74.63% |
| Q1 2022 Q2Q % growth | 970K -91.38% | 5.155M | -4.185M | -81.18% |
| Q4 2021 Q2Q % growth | 1.01M -98.32% | 113.1M | -112.09M | -99.11% |
| Q3 2021 Q2Q % growth | 20.89M | 6.808M | 14.082M | 206.84% |
| Q2 2021 Q2Q % growth | 30.03M | 29.459M | 571K | 1.94% |
| Q1 2021 Q2Q % growth | 11.25M -25.00% | 9.577M | 1.673M | 17.47% |
| Q4 2020 Q2Q % growth | 60M | 65.28M | -5.28M | -8.09% |
| Q3 2020 Q2Q % growth | 1.7M | -1.7M | -100.00% | |
| Q2 2020 Q2Q % growth | 2.368M | -2.368M | -100.00% | |
| Q1 2020 Q2Q % growth | 15M | 6.375M | 8.625M | 135.29% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.37% | 726.63% | -1.78% | 69.7% |
| Revenue | -0.81% | 37.26% | 0.02% | 71.25% |